Overview
Werfen Polska offers diagnostic products for hemostasis, acute care, transfusion, autoimmune diseases and transplantation. Its portfolio includes in vitro diagnostic systems, reagents, automated instruments, data management software and services.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 127 days early. All were audited by a statutory auditor.
- 202512/03/2026
- 202424/02/2025
- 202309/04/2024
- 202205/04/2023
- 202123/03/2022
- 202014/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Hemostasis diagnostic systems
- Diagnostic reagents
- Acute care diagnostic systems
- Transfusion diagnostic systems
- Autoimmunity diagnostic systems
- Laboratory data management software
Website technology
- Website
- Drupal
Public procurement
329 tenders recorded as contractor: 150 national ($9,825,854) and 179 EU ($35,956,441).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 22, 2026 | Supply of reagents, calibration and control materials, consumables and additional accessories for coagulation parameter testing, including lease of analysers and auxiliary equipment, chemical reagents, urease tests, cuvettes and consumables for a gas spectrometer for uckwum for a period of 12, 24 and 36 months | $1.2M$1,177,716 | Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego | |
| Oct 20, 2026 | Supply of reagents together with the lease of analysers | $178K$177,991 | Narodowy Instytut Geriatrii,Reumatologii I Rehabilitacji Im. Prof. Dr Hab. Med. Eleonory Reicher | |
| Oct 20, 2026 | Successive supply of small laboratory equipment, divided into 5 lots, for Zakłady i Kliniki umb | $11,809$11,809 | Uniwersytet Medyczny w Białymstoku |
Authorized Representatives
Manner of representation
If the management board is a one-person management board, the company is represented by the member of the management board independently. If the management board is a multi-member management board, the company is represented by a member of the management board jointly with another member of the management board or a commercial proxy. The commercial proxy represents the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Werfen Italy Investments S.r.l. | 12,000 | $3,241,491.09 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-04-30.
31 1750 0009 0000 0000 1326 4384- 86 1750 0009 0000 0000 2077 8954
- 59 1750 0009 0000 0000 2051 8898
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 28,531PLN 28,531 |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sysmex Polskasp. z o.o. | $37,091,282.03 | sysmex.pl | ||
| DS Food Polandsp. z o.o. | $32,894,560.47 | foodpoland.com.pl | ||
| Euroimmun Polskasp. z o.o. | $30,318,011.37 | euroimmun.pl | ||
| Consultronixsp. z o.o. | $29,089,133.20 | consultronix.pl | ||
| Bionesissp. z o.o. | $7,788,948.87 | bionesis.pl | ||
| Diather Petrusewiczsp. k. | $7,399,375.09 | diather.pl | ||
| Biochem PolskaS.A. | $7,311,179.43 | biochempolska.pl | ||
| Mindray Medical Polandsp. z o.o. | $6,479,161.67 | mindray.com | ||
| Polmilsp. z o.o. | $6,332,250.91 | polmil.pl | ||
| Medlab-Productssp. z o.o. | $3,179,760.29 | medlab-products.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-10-03 | Address change (Wolińska 4, 03-699, Warszawa → Ul. Prosta 67, 00-838, Warszawa) | |
| 2015-03-19 | PKD change (Removed: 20 codes) | |
| 2012-04-30 | Entered in the register |
FAQ
Last updated: 2026-08-19